Researchers tested a mobile journaling platform designed to monitor behavior and risk in young adults experiencing mild-to-moderate anxiety and depression. The study included 507 participants who used the digital journaling tool, while others served as controls who did not use the platform. The primary goal was to see if the intervention could reduce anxiety symptoms over an eight-week period with a one-month follow-up.
The main finding was that digital journaling produced modest reductions in anxiety relative to controls. However, these effects were small and did not remain significant after correction for multiple comparisons. The study also found that high-risk journal entries were more common among younger users and that risk probability was highest during late-night and overnight hours.
Regarding mood changes, the data showed that affective volatility was associated with acute declines within the same affective dimension. Importantly, this volatility was not associated with an escalation to high-risk states. No safety concerns or adverse events were reported during the study. While the trial design supports a causal link for the small anxiety reduction, the overall evidence suggests the benefit is modest and should be viewed with caution.
Readers should take from this that privacy-preserving digital journaling can support scalable monitoring and provide some clinical benefit for anxiety symptoms. However, the small effect size and lack of significance after statistical correction mean this should not be seen as a definitive treatment solution.